Growing disease burden globally continues to baffle mankind, and under prevailing conditions it is estimated that under prevailing conditions, severity of chronic ailments and wide scale prevalence of the same are likely to remain sky-high. Needless to mention, drug manufacturers are fast embracing novel technological aid to peruse palpable breakthroughs in drug design and therapeutics. Additionally, concurrent rise and optimistic outlook of healthcare infrastructure, more emphatically across emerging economies aided by lucrative funding at both public and private realms are poised to support rapid progress in novel therapeutics.

On the back of staggering federal government initiatives towards improved healthcare matrix, international competition spectrum of disease therapeutics is characterized by several global, regional, as well as local players who are treading continually towards achieving superlative therapeutic means to ease out global disease burden.

Rise in chronic diseases and their imitated therapeutic scope has accentuated adherence to novel corrective procedures such as stem cell culture for optimal cell renewal. Therefore, need for regenerative medicine to govern regeneration of organs. Therefore, to effectively carry out flawless stem cell culture, adoption of cell culture protein surface coating materials has been garnering ample attention at a global level. Surface Protein coatings remain integral components to aid accelerated cell growth under controlled lab conditions triggered by effective cell cohesion. In this light, the g market is expected to demonstrate lucrative prospects in the coming years.

Regenerative medicine which is experiencing far flung advances and is identified as the latest boon in therapeutics strongly depends on stem cell culture, aided by cell culture protein surface coatings. It broadly enables restoration of dead, defunct tissues led by acute chronic disease or sudden trauma and accidents. Regenerative medicines comes to the fore to offset limitations of conventional, standard medication. Disease modelling, therapies, and drug structure, accurate and potential cell culture conditions for effective cellular therapies to comply with accurate self-renewal necessitate adoption of cell culture protein surface coating, encouraging rapid growth. Extracellular matrix proteins which serve as integral surface coatings for development and culture of human pluripotent stem cells necessitate self-renewal amidst in-vitro cell culture conditions.

Dating back to the advances of cell culture and concomitant drug discovery, cells have most often been cultured under controlled lab conditions in 2D environments. Therefore extracellular proteins remained an integral parameter in such stem culture initiatives. Adoption of such extracellular matrix proteins facilitate apoptosis and receptor expression. However, 2D mediated cell culture fail to be transformed completely into successful clinical trials. Therefore, emergence of 3D stem cell culture has been meticulously developed to address prevailing loopholes and challenges of 2d cell studies. Such progresses in stem cell culture are poised to incur lingering growth patterns in global cell culture protein surface coating market in forthcoming years.